SEC Form 4 · accession 0001209191-17-046282
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Gregoire
Officer — General Counsel and Secretary
Period of report
Jul 25, 2017
Accepted (ET)
Jul 26, 2017 · 3:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Jul 25, 2017 | X | 4,559 | $49.10 | A | 18,016 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Jul 25, 2017 | S | 4,559 | $80.6799 | D | 13,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F4,F3 | $49.10 | Jul 25, 2017 | X | 4,559 | D | — | Mar 3, 2021 | Common Stock | 4,559 | 0 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $80.65 to $80.70, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3All of the stock options in this tranche have vested in full.
- F4Not applicable.